4.1.1.53	Ataxia	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33889127&form=6&db=m	Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials.	therapeutic application,unassigned	1,0	
4.1.1.53	Carcinogenesis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24467211&form=6&db=m	Glycine decarboxylase is an unusual amino acid decarboxylase involved in tumorigenesis.	causal interaction,unassigned	3,0	
4.1.1.53	Carcinoid Tumor	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=13928592&form=6&db=m	[Amino acid decarboxylase in pheochromocytoma and carcinoid tissue.]	causal interaction,ongoing research,unassigned	1,2,0	
4.1.1.53	Cerebral Palsy	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1078720&form=6&db=m	Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486.	diagnostic usage,therapeutic application,unassigned	3,1,0	
4.1.1.53	Dyskinesias	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=159153&form=6&db=m	[Serum dopamine-beta-hydroxylase, glutamic acid decarboxylase and 1-aromatic amino acid decarboxylase in involuntary movement disorders (author's transl)]	diagnostic usage,unassigned	1,0	
4.1.1.53	Dystonia	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25597765&form=6&db=m	Syndromic intellectual disability: A new phenotype caused by an aromatic amino acid decarboxylase gene (DDC) variant.	causal interaction,unassigned	3,0	
4.1.1.53	Dystonia	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33889127&form=6&db=m	Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials.	therapeutic application,unassigned	1,0	
4.1.1.53	Huntington Disease	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33889127&form=6&db=m	Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials.	therapeutic application,unassigned	1,0	
4.1.1.53	Hypotension, Orthostatic	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18368303&form=6&db=m	L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.	therapeutic application,unassigned	1,0	
4.1.1.53	Hypothyroidism	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7389157&form=6&db=m	TSH and prolactin stimulation by the decarboxylase inhibitor benserazide in primary hypothyroidism.	diagnostic usage,ongoing research,therapeutic application,unassigned	3,1,2,0